(Q38130897)

29 August 2017

title

Staphylococcus aureus in early cystic fibrosis lung disease (English)

1 reference

29 August 2017

0 references

Staphylococcus aureus

1 reference

John K Wong

1

1 reference

29 August 2017

Sarath C Ranganathan

series ordinal

2

1 reference

29 August 2017

Emily Hart

series ordinal

3

1 reference

29 August 2017

Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF)

series ordinal

4

1 reference

29 August 2017

publication date

22 August 2013

1 reference

29 August 2017

published in

Pediatric Pulmonology

1 reference

29 August 2017

volume

48

1 reference

29 August 2017

issue

12

1 reference

29 August 2017

page(s)

1151-1159

1 reference

Staphylococcal infections: a historical perspective

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Review: Staphylococcus aureus and MRSA in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Complex molecular epidemiology of methicillin-resistant staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Infection, inflammation, and lung function decline in infants with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Structural airway abnormalities in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Cystic fibrosis since 1938.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Lung transplantation and survival in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Predictive 5-year survivorship model of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

The natural history of contemporary Staphylococcus aureus nasal colonization in community children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Staphylococcus aureus nasal colonization among pediatric cystic fibrosis patients and their household contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Nasal Staphylococcus aureus carriage is not a risk factor for lower-airway infection in young cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Persistence of Staphylococcus aureus strains among cystic fibrosis patients over extended periods of time

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Sinus surgery in cystic fibrosis patients: comparison of sinus and lower airway cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Staphylococcus aureus escapes more efficiently from the phagosome of a cystic fibrosis bronchial epithelial cell line than from its normal counterpart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Increased frequency of genomic alterations in Staphylococcus aureus during chronic infection is in part due to phage mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

The role of bacterial adhesion in cystic fibrosis including the staphylococcal aspect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Increased adherence of Staphylococcus aureus from cystic fibrosis lungs to airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Temporal expression of adhesion factors and activity of global regulators during establishment of Staphylococcus aureus nasal colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Lung pathology in response to repeated exposure to Staphylococcus aureus in congenic residual function cystic fibrosis mice does not increase in response to decreased CFTR levels or increased bacterial load

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Murine models of acute and chronic lung infection with cystic fibrosis pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

The porcine lung as a potential model for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Predictive Value of Oropharyngeal Cultures for Identifying Lower Airway Bacteria in Cystic Fibrosis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Bacterial reservoirs in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Pulmonary function in infants with cystic fibrosis: the effect of antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Prophylactic antibiotics in cystic fibrosis: a conviction without evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Clindamycin therapy of staphylococcal pulmonary infections in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Antibiotic treatment of Staphylococcus aureus infection in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Update on the epidemiology and management of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Early intervention and prevention of lung disease in cystic fibrosis: a European consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22863

21 January 2018

Identifiers

DOI

10.1002/PPUL.22863

1 reference

29 August 2017

1 reference